Charles A. Reinhart III - Jun 3, 2024 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Financial Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Jun 3, 2024
Transactions value $
-$92,021
Form type
4
Date filed
6/5/2024, 05:09 PM
Previous filing
Jun 16, 2023
Next filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Tax liability -$92K -2.98K -6.99% $30.89 39.6K Jun 3, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.